Procter & Gamble is facing a growing multidistrict litigation consisting of patients alleging Prilosec chronic kidney disease. One of the most recent claims comes from a Massachusetts woman, alleging the companies failed to warn her loved one against Prilosec kidney disease risk.

Plaintiff Donna G. is filing legal action on behalf of her deceased mother Doris G., alleging Doris died as a direct result of Prilosec chronic kidney disease. According to her Prilosec kidney disease lawsuit, Doris had been prescribed Prilosec OTC for typical treatment purposes in June 2007.

Prilosec is a popular medication often used to treat acid reflux and ulcers. Doris had used the medication up through October 2014. She allegedly used the drug according to prescription instructions and did not deviate from the label instructions.

Even though Doris followed the prescription instructions carefully, she allegedly developed acute renal failure and chronic kidney disease during the course of her Prilosec treatment. Doris was reportedly diagnosed with Prilosec chronic kidney disease in early 2010, and eventually died from sudden death from the disease on Oct. 21, 2014.

Donna opted to file legal action against Procter & Gamble, after discovering the company may have known their drug’s potential link with deadly kidney problems. During all times relevant, Donna says, neither Doris nor her physicians received warnings or precautions from the company regarding dangers of Prilosec chronic kidney disease.

Overview of Prilosec and Nexium Kidney Problems

Prilosec is one of the popular drug class of proton pump inhibitors (PPIs). Along with Nexium, Prilosec works by limiting the amount of stomach acid secreted in the gastrointestinal system.

Even though these medications are used by millions of patients on a daily basis, PPIs have been allegedly linked to chronic kidney problems. One of the most recent studies found that patients who take Prilosec and Nexium have a 96% increased risk of kidney failure, compared to the control group who experienced a 28% increased risk.

The study was published in the Journal of the American Society of Nephrology, with researchers observing the different effects of PPIs and histamine H2 receptor blockers. Another study found similar results, published in the February 2016 issue of the Journal of the American Medical Association (JAMA).

Researchers found that PPIs drastically increased the risk of acute interstitial nephritis, which is a condition that often leads to kidney failure. It is important to note that a couple of years earlier, in 2014, the FDA approved a label change for Nexium to include warnings for potential interstitial nephritis.

Prilosec has also been associated with an elevated risk of kidney problems. Approximately 15 million Americans are prescribed Prilosec and Nexium, but the total number of users is probably much higher due to over the counter variants.

Even though kidney failure can be devastating and fatal to patients, Procter & Gamble allegedly failed to disclose this information to the public. Donna is filing her Prilosec kidney disease lawsuit in MDL No. 2789, where it will stand alongside other claims alleging similar injuries.

Donna states her mother never would have agreed to take the medication if she had known about the possibility of Prilosec chronic kidney disease.

This Prilosec Kidney Disease Lawsuit is Case No. 2:17-cv-08608-CCC-MF, in the U.S. District Court of New Jersey.